Trial site
Shandong Cancer Hospital and Institute
- 22running trials
- 5closed trials
The trials here
What the 28 trials at this site are about, from their registry records.
- Conditions
- Lung cancer7 trials
- Liver and biliary tract cancer6 trials
- Pancreatic cancer5 trials
- Childhood cancers2 trials
- Colorectal cancer2 trials
- Diffuse large B-cell lymphoma1 trial
- Gastric and oesophageal cancer1 trial
- Metastatic breast cancer1 trial
- Neuroblastoma1 trial
- Sarcoma1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 217 trials
- Phase 35 trials
- Phase 12 trials
- Phase 1/21 trial
- Phase 2/31 trial
- Status
- Recruiting16 trials
- Completed4 trials
- Active, not recruiting3 trials
- Not yet recruiting3 trials
- Suspended1 trial
- Terminated1 trial
- Lead sponsor
- Shandong Cancer Hospital and Institute14 trials
- BioNTech SE2 trials
- Jinbo Yue2 trials
- Lei ZHAO2 trials
- Shandong First Medical University2 trials
- and 6 more
Running trials
Recruiting
Recruiting
Recruiting
A Phase II Study of AMT-676 Combination Therapies in Advanced Colorectal Cancer
Active, not recruiting
Recruiting
Recruiting
Recruiting
Stereotactic Body Radiotherapy and NALIRIFOX for Locally Advanced Pancreatic Cancer
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Neoadjuvant WX-0593 in Resectable ALK-positive or ROS1-positive Non-small Cell Lung Cancer
Recruiting
TAA06 Injection in the Treatment of Patients With B7-H3-positive Relapsed/ Refractory Neuroblastoma
Recruiting
Neoadjuvant Camrelizumab Combined With Chemotherapy for Resectable Stage IIIA-IIIB NSCLC
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Liver and biliary tract cancer4 recruiting
- Pancreatic cancer4 recruiting
- Lung cancer3 recruiting
- Colorectal cancer2 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Metastatic breast cancer1 recruiting
- Neuroblastoma1 recruiting
- Sarcoma1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Terminated
SBRT Plus Systemic Therapy vs Systemic Therapy Alone in BCLC C Hepatocellular Carcinoma
Completed
CXCR4 PET/CT for Predicting Outcome in Limited-Stage Small Cell Lung Cancer
Completed
Thalidomide Combined With Chemotherapy in the Treatment of Relapsed or Refractory Yolk Sac Tumor
Completed
Completed
Clinical Study of Chemotherapy in the Treatment of Recurrent/Refractory Yolk Sac Tumor in Children
Site data: ClinicalTrials.govUpdated 19 Nov 2026